Mumbai, December 17, 2024 – Granules India Limited, a vertically integrated Indian pharmaceutical company, announced today that its wholly-owned foreign subsidiary, Granules Pharmaceuticals, Inc. (GPI), has received approval from the U.S. Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Lisdexamfetamine
Range of products for women aged 35-55 years during the menopausal phase Effective, holistic, science-backed targeted solutions for symptomatic treatment Convenient to use and carry to keep their health in control Emcure Pharmaceuticals Ltd., a leading Indian pharma company with a strong focus on women’s
Debabrata Auro Foundation (DAF) and The Esthetic Clinics (TEC) collaboratively organized a Fungal Infection Check-Up Camp and Free Medicines Distribution at BMC Chowki, Near Bandra Court. This initiative targeted the BMC Safai Karmcharis to address the prevalent issue of fungal infections within this community. DAF,
Sevelamer Carbonate Tablets approval consolidates the Company's position in the Sevelamer segment by complementing the existing approval of Sevelamer for Oral Suspension Strides Pharma Science Limited (Strides) today announced that its step-down wholly owned subsidiary, Strides Pharma Global Pte. Limited, Singapore, has received approval
